Prescription Narcotics Market Overview

Prescription narcotics are a type of drug that has the potential to be addictive. Because of their addictive potential, this type of drug should only be used according to a doctor’s specific prescription. These narcotics are also used as pain killers to relieve pain from the body and this narcotic work in the body by binding themselves to pain receptors in the nervous system so that the pain signals are blocked. As a result, this type of drug is sometimes prescribed to temporarily treat severe pain that doesn’t respond to other forms of pain relievers.

Increasing demand of opioids in clinical practice for treating chronic pain conditions is fuelling the growth of the market. Along with increasing demand, rising prevalence of chronic pain is expected to boost the utilization of narcotics in effective chronic pain treatment. According to CDC, 11% of adult population in the US is experiencing some form of chronic pain. Further, changing regulatory conditions to encourage the utilization of narcotics in better management of pain led to potential growth of the market. Further, opioids are only available effective therapy for severe pains when compared to alternatives treatment options. All these factors led to potential growth of the market during forecast period. 

Global market is dominated by North America market due to supportive regulatory environment. It is expected to remain dominant throughout forecast period and it witnessed a large number of manufacturers. It is followed by Europe market due to high adoption of opioids for effective management of pain. Asia Pacific and Latin America is fast growing region due to increasing adoption of opioids in clinical practice. Further, high prevalence of chronic pain in these regions is expected fuel the growth of the market. Rest of World is also fast-growing region due to increasing adoption among end-user segment led to potential growth of the market.

Global Prescription Narcotics market players include
Pfizer Inc, Novartis AG, J&J, Merck Co. & Inc, Roche Holding, Bayer AG, AstraZeneca, Sanofi Plc and others

Prescription Narcotics Market

Prescription Narcotics Market Segmentation

By Indication

  • Cancer Pain
  • Trauma
  • Analgesics
  • Others

By Sales Channel

  • Retail Pharmacies
  • Institutional Distribution

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Rest of the World

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 

•    To provide with an exhaustive analysis on the global Prescription Narcotics Market by Indication, by Sales Channel, and by Region

•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics